Impaired or dead tumor cells release damage-associated molecular patterns (DAMPs) including ATP, calreticulin (CRT) and high mobility group box 1 (HMGB1) to activate dendritic cells (DCs) and subsequent T cells for anti-tumor immunity initiation 32. The gene discussed is HMGB1; the disease is neoplasm.